cetrorelix

Ukraine

Drugs containing this active substance

  • CETRORELIX® 0.25 MG

    The drug is used to prevent premature ovulation in women during controlled ovarian stimulation when subsequent oocyte retrieval and the use of assisted reproductive technologies are planned.

    Form: powder and solvent for injection solution

    Active substance Dosage
    cetrorelix 0.25 mg

    ATC: H01CC02

    Manufacturer: Baxter Oncology GmbH (manufacturer of unpackaged products, primary packaging and quality control)